Unveiling the predictive role of systemic inflammation marker in mortality outcomes: a nationwide analysis of cancer survivorship in the United States.

ABSTRACT:

Purpose

This study aims to provide a simple indicator for predicting the prognosis of cancer survivors and offer reference and guidance for management strategies to ultimately improve their long-term prognosis.

Methods

Based on data from the 1999-2019 National Health and Nutrition Examination Survey, we included 3436 cancer survivors in this study. Participants were defined as cancer survivors if they had been previously diagnosed with cancer by a doctor or health professional. The neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and systemic inflammatory response index (SIRI) were used as systemic inflammatory markers. Survival status was determined by linking it with National Death Index records. Associations between systemic inflammatory markers a

SUBMITTER: Cai A 

PROVIDER: S-EPMC12271561 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature